Contract Pharma Contract Pharma Talks with Jim Donovan of Pfizer CentreOne. Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.

Stay informed with the latest financial reports and updates in the pharma industry. View all

Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry. View all

1 天前 · The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to ACTEMRA.. AVTOZMA is indicated for the treatment of multiple diseases including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (pJIA), systemic juvenile ...

Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry. View all

Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com and social media channels.

The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

LGM Pharma’s chief executive talks industry trends and the company’s continued growth as a provider of tailored API and CDMO services. Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors ...

News Releases Former Assets of a cGMP Contract Research Organization – Multi Location Auction. Federal Equipment Company and Proxio Group are collaborating to auction off the former assets of a cGMP Contract Research Organization.

VideoBites Videobite: Contract Pharma Sits Down with Steve Smith of Solvias. General Manager of Solvias U.S. discusses the company's new facility in RTP, NC and its unique capabilities in the cell and gene therapy space.